MEDICINES
PATIENT ASSISTANCE PROGRAMS
IMPORTED MEDICINES
CONTACT US
Upload
Introduction to Borzomed 3.5mg Injection
Borzomed 3.5mg Injection is a chemotherapy medication classified as a proteasome inhibitor. Its active ingredient is Bortezomib. This medication is used to treat multiple myeloma and mantle cell lymphoma. Multiple myeloma involves the cancerous growth of plasma cells primarily in the bone marrow, while mantle cell lymphoma is a rarer cancer affecting the lymph nodes. Velcade is often used in combination with other chemotherapy drugs such as pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone, or thalidomide for patients who have not begun treatment and are not eligible for blood stem cell transplants.
Common side effects of Borzomed 3.5mg Injection include pneumonia, loss of appetite, sensitivity, tingling and burning sensations in the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, infections, itching, redness, dehydration, and stomach problems. If these side effects are bothersome or persistent, inform your physician.
Uses of Borzomed 3.5mg Injection
- Treatment of multiple myeloma and mantle cell lymphoma.
Therapeutic Effects of Borzomed 3.5mg Injection
Borzomed 3.5mg Injection works by exerting a toxic effect on cancer cells. It inhibits the 26S proteasome, blocking a major cell signaling pathway, which makes cancer cells more sensitive to chemotherapy. Additionally, this medication promotes the accumulation of a protein that reduces the growth and multiplication of cancer cells.
Interaction of Borzomed 3.5mg Injection with other drugs
Inform your doctor about all prescription and over-the-counter medications, nutritional or vitamin supplements, and herbal products you are currently taking or have taken before starting treatment. Some medications may interact with Borzomed 3.5mg Injection and cause undesirable side effects.
More Information about Borzomed 3.5mg Injection
- Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.
- Keep this medicine out of sight and reach of children.
How to consume Borzomed 3.5mg Injection
Borzomed 3.5mg Injection is administered intravenously in your vein or subcutaneously under the skin. This injection should be given by a qualified healthcare professional experienced in the use of cytotoxic medications. Do not self-administer.
Safety Advices
Pregnancy
Unsafe to use during pregnancy unless clearly necessary. Both women of childbearing potential and men must use an effective contraception method during and three months after treatment.
Breast Feeding
Unsafe to use during breastfeeding. Please discuss with your physician when it is safe to restart breastfeeding after this treatment.
Lungs
It is unknown whether can be given to lung failure patients. Please consult your physician if you have any lung diseases.
Liver
Inform your physician before starting this treatment if you have Hepatitis infection or liver disease. Your physician will monitor your liver functions regularly.
Alcohol
It is unsafe to consume alcohol with this medication. may cause excessive drowsiness with alcohol. Please consult your doctor for more advice.
Driving
Avoid driving or using machinery if you experience side effects like fainting, dizziness, tiredness, or blurred vision.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Muscle cramps
- Confusion, visual disturbances, seizures, and headache
- Breathlessness
- Swelling of feet
- Changes in heartbeat
- High blood pressure
- Fainting and tiredness
- Cough and chest tightness
Common
- Pneumonia
- Loss of appetite
- Sensitivity, tingling and burning sensation of the skin
- Nausea, vomiting, and diarrhea
- Mouth ulcers
- Constipation
- Muscle and bone pain
- Hair loss
- Fever
- Reduction in blood cell count
- Reduced kidney function
- Shivering
- Infections
- Itching and redness
- Dehydration
- Stomach problems
- Difficulty sleeping, anxiety, mood swings, depressed mood
Word of Advice
Both men and women are advised to use effective contraception during treatment and for three months afterward. can commonly cause a decrease in red and white blood cells and platelets. Therefore, regular blood tests will be necessary before and during your treatment with bortezomib to monitor your blood cell counts. Pregnant women should not handle this injection due to its cytotoxic agents. It is recommended to use gloves and protective clothing to prevent skin contact.
FAQs
Q 1. What is Borzomed 3.5mg Injection used for?
Borzomed 3.5mg Injection is mainly indicated to treat mantle cell lymphoma and multiple myeloma.
Q 2. Can I drive while taking Borzomed 3.5mg Injection?
Borzomed 3.5mg Injection may cause dizziness, tiredness, fainting, or blurred vision. Hence, avoid driving and operating heavy machines while this Injection.
Q 3. How is Borzomed 3.5mg Injection given?
Borzomed 3.5mg Injection is administered intravenously in your vein or subcutaneously under the skin by a doctor in a medical facility.
Fact Box
Molecule name: Bortezomib
Pharmacological class: Proteasome inhibitor
Therapeutic class: Antineoplastics agents
Indications:
1. Multiple myeloma
2. Mantle cell lymphoma
Reviews
There are no reviews yet.